# US 2005/0232989 A1 · Process for preparing oral calcium compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0232989 A1
- Document ID: US20050232989A1
- Status: Published application
- Kind: A1
- Application number: 10/973,352
- Filed: 2004-10-27
- Published: 2005-10-20
- Earliest claimed: 1998-11-13
- Inventors: Jan Piene; Dina Schmidt
- Web page: https://patentgrep.com/patent/US20050232989A1

## CPC

- A61K 9/0007: {Effervescent (A61K9/0065 takes precedence)}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/2018: {Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates}
- A61K 9/2027: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/2077: {Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets}
- A61P 19/10: for osteoporosis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A process for the preparation of an orally administrable calcium composition comprising the steps of: (i) obtaining a physiologically tolerable particulate calcium compound having a mean particle size in the range 3 to 40 μm, having a crystalline structure and having a surface area of 0.1 to 1.2 m2/g; (ii) mixing the calcium compound with a water-soluble diluent and an aqueous solution of a water soluble binder in a fluid bed granulation apparatus and drying the resulting mixture to produce a first granulate; (iii) optionally mixing the first granulate with one or more further components to produce a second granulate; and (iv) optionally compressing the first or second granulate to form tablets.

## Claims

### Claim 1

A process for the preparation of an orally administrable calcium composition, sad process comprising the steps of:
(i) obtaining a physiologically tolerable particulate calcium compound having a mean particle size in the range of 3 to 40 μm, having a crystalline structure and having a surface area of 0.1 to 1.2 m2/g;
(ii) mixing said calcium compound with a water-soluble diluent and an aqueous solution of water soluble binder in a fluid bed granulation apparatus and drying the resulting mixture to produce a first granulate;
(iii) optionally mixing said first granulate with one or more further components to produce a second granulate;
(iv) optionally compressing said first or second granulate to form tablets.

### Claim 2 (depends on 1)

A process as claimed in claim 1 wherein said calcium compound is selected from calcium carbonate, calcium lactate, calcium gluconate, calcium citrate, calcium glycerophosphate, calcium phosphate, calcium hydrogen phosphate, calcium glucuronate, calcium aspartate, calcium glucoheptonate and mixtures of two or more thereof.

### Claim 3 (depends on 1)

A process as claimed in claim 1 wherein said calcium compound is calcium carbonate.

### Claim 4 (depends on 3)

A process as claimed in claim 3 wherein said calcium compound makes up 68 to 80% wt. of said first granulate.

### Claim 5 (depends on 3)

A process as claimed in claim 3 wherein said calcium compound makes up 60 to 95% wt. of said second granulate.

### Claim 6 (depends on 3)

A process as claimed in claim 3 wherein in step (ii) the same material is used as said diluent and as said buffer.

### Claim 7 (depends on 3)

A process as claimed in claim 3 wherein said water-soluble diluent comprises at least one sweetener.

### Claim 8 (depends on 7)

A process as claimed in claim 7 wherein said sweetener is at least one component selected from the group consisting of sorbitol, xylitol, isomalt, mannitol, sucrose, fructose, maltodextrin, inulin and oligofructose.

### Claim 9 (depends on 3)

A process as claimed in claim 3 wherein said water-soluble diluent makes up 70-96% wt. of the total weight of said water-soluble diluent and said water-soluble binder in said first granulate.

### Claim 10 (depends on 3)

A process as claimed in claim 3 wherein said water-soluble binder is selected from the group consisting of celluloses, polysaccharides, maltodextrin, inulin and polyvinylpyrrolidone.

### Claim 11 (depends on 3)

A process as claimed in claim 3 wherein said water-soluble binder is polyvinylpyrrolidone.

### Claim 12 (depends on 3)

A process as claimed in claim 3 wherein said first granulate has a particle size distribution of D(V, 0.1)0 15-21 μm, D(V, 0.5)=70-120 μm and D(V, 0.9)=190-330 μm.

### Claim 13 (depends on 3)

A process as claimed in claim 3 wherein a said further component is mixed with said first granulate, said further component being at least one component selected from the group consisting of: vitamin B6, vitamin K, vitamin C, vitamin D, isoflavones, inulin, and oligofructose and mixtures of two or more thereof.

### Claim 14 (depends on 3)

A process as claimed in claim 3 wherein in step (ii) said calcium compound is also mixed with isoflavones.

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)

### Claim 21

(canceled)
